![]() |
NPI Articles:
All Providers:
CAP/DA Lead Agencies:
Children’s Developmental Service Agencies:
Community Alternatives Program Case Managers:
Dialysis Providers:
Federally Qualified Health Centers:
Health Departments:
Home Health Agencies:
Independent Laboratories:
Independent Practitioners:
Institutional (UB-92/UB-04) Claim Billers:
Local Management Entities:
Nurse Midwives:
Nurse Practitioners:
Pharmacists:
Physicians:
Private Duty Nursing Providers:
Rural Health Clinics:

To ensure that claims continue to process correctly after the implementation of the National Provider Identifier (NPI), providers should verify that their Medicaid-to-Medicare crosswalk information is accurate. The NPI associated with the Medicaid and the Medicare number in the crosswalk must be the same. This can be verified by reviewing the crossover claims section of your Remittance and Status Advice (RA) or by calling EDS Provider Services.
Submit updates using the Medicare Crossover Reference Request form.

DMA continues to adjudicate claims for providers
who have been end-dated when the claims are for dates of service prior
to the provider’s end-date. To date, over 6,000 providers
who were end-dated during the past 12 months have not reported their National
Provider Identifier (NPI) to DMA. After
To report your NPI or to verify that your NPI has been received, please access the NPI and Address Information database.
If all information is correct, no action is necessary. If the NPI column is blank, your NPI has not been reported. Print the form and submit your NPI with a copy of the National Plan and Provider Enumeration System (NPPES) certification.

As defined in the National Provider Identifier (NPI) final rule, an “atypical” provider is an individual or business that does not meet the traditional definition of a health care provider, but is eligible to bill for health-related services covered by some health plans.
Because some types of Medicaid-enrolled providers may be atypical, after the implementation of NPIs, a legacy Medicaid provider number may still be acceptable as the referring provider number entered on a claim. However, it is the billing provider’s responsibility to verify that the referring provider is atypical and that a legacy Medicaid provider number is acceptable.
The atypical status of a provider may be verified by visiting the NPI and Address Information database. The database may be searched by the legacy Medicaid provider number. When a result is returned, the word “atypical” will be displayed under the legacy Medicaid provider number located in the “Provider No.” column if DMA recognizes the provider as atypical. If the “NPI” column is blank or an NPI is displayed, this means that DMA does not recognize this provider as atypical. Providers must contact the referring source to obtain the NPI.
CMS has reviewed its policy regarding tamper-resistant prescriptions and has provided two updates to that policy.
Provider Additions to Otherwise Non-tamper-resistant Paper
Several
states have questioned whether a provider can add a feature to a prescription
to make it compliant with
the tamper-resistant prescription pad requirements. States
have proposed various features, including particular kinds of ink to write
the prescription (gel or indelible); writing out drug quantities rather
than just the number ("thirty" vs. "30"); and embossed
logos. The tamper-resistant prescription pad statute states
that all written prescriptions must be "executed on a tamper-resistant
pad." As a result, features added to the prescription
after the pads are printed do not meet the requirement of the statute. Features
that would make the prescription tamper-resistant include certain types
of paper as well as certain items that can be pre-printed on the paper.
Computer-generated Prescriptions
CMS has further clarified that during
the period between April 1, 2008 and October 1, 2008, computer-generated
prescriptions
printed by a provider on plain paper, including electronic medical record
computer-generated prescriptions, may meet CMS guidance by containing one
or more industry-recognized features designed either to prevent the erasure
or modification of information contained on the prescription, or to prevent
the use of counterfeit prescription forms. However, based
on its understanding of current prescription security technology, CMS does
not believe that computer-generated prescriptions printed by a prescriber
on plain paper will be able to meet the first baseline requirement that
prescriptions contain one or more industry-recognized
features designed to prevent unauthorized copying of a completed or blank
prescription form. In other words, prescriptions printed
on plain paper will not be able to meet all three baseline characteristics
outlined by CMS. Therefore, beginning
Please refer to the DMA
guidance document dated
Effective with date of service
|
NDC |
Drug Label Name |
Pkg Sz |
|---|---|---|
|
00378363501 |
Cetirizine HCl 5-mg tablet |
100 |
|
00378363701 |
Cetirizine HCl 10-mg tablet |
100 |
|
00378363705 |
Cetirizine HCl 10-mg tablet |
500 |
|
00781168301 |
Cetirizine HCl 5-mg tablet |
100 |
|
00781168401 |
Cetirizine HCl 10-mg tablet |
100 |
|
00904582941 |
Cetirizine HCl 10-mg tablet |
14 |
|
00904582943 |
Cetirizine HCl 10-mg tablet |
45 |
|
00904582946 |
Cetirizine HCl 10-mg tablet |
30 |
|
00904582989 |
Cetirizine HCl 10-mg tablet |
90 |
|
24385017574 |
Cetirizine HCl 10-mg tablet |
14 |
|
45802091987 |
Cetirizine HCl 10-mg tablet |
300 |
|
50580072013 |
Zyrtec 5-mg chewable tablet |
5 |
|
50580072219 |
Zyrtec 10-mg chewable tablet |
12 |
|
50580072410 |
Zyrtec 1-mg/ml syrup |
118 |
|
50580072511 |
Zyrtec 1-mg/ml syrup |
118 |
|
50580072630 |
Zyrtec 10-mg tablet |
5 |
|
50580072632 |
Zyrtec 10-mg tablet |
14 |
|
50580072636 |
Zyrtec 10-mg tablet |
30 |
|
50580072638 |
Zyrtec 10-mg tablet |
45 |
|
50580072734 |
Zyrtec 10-mg tablet |
14 |
|
51079059701 |
Cetirizine HCl 10-mg tablet |
100 |
|
51660093854 |
Cetirizine HCl 10-mg tablet |
14 |
|
57664034315 |
Cetirizine HCl 5-mg chewable tablet |
30 |
|
57664034383 |
Cetirizine HCl 5-mg chewable tablet |
30 |
|
57664034415 |
Cetirizine HCl 10-mg chewable tablet |
30 |
|
57664034483 |
Cetirizine HCl 10-mg chewable tablet |
30 |
|
60505263201 |
Cetirizine HCl 5-mg tablet |
100 |
|
60505263301 |
Cetirizine HCl 10-mg tablet |
100 |
The list of covered OTC drug codes is available in General Medical Policy #A2, Over-the-Counter Medications.
The following new or amended clinical coverage policies are now available:
1K-1, Breast Imaging Procedures
1R-4, Electrocardiography, Echocardiography,
and Intravascular Ultrasound
3B, Program of All-inclusive Care for
the Elderly (PACE)
Additionally, the list of drugs in General Medical
Policy #A2, Over-the-Counter Medications, has been updated
effective
These policies supersede previously published policies and procedures. Providers may contact EDS at 1-800-688-6696 or 919-851-8888 with billing questions.
All providers participating in the Medicaid program are required to submit to DMA, Third Party Recovery Section, a quarterly Credit Balance Report indicating balances due to Medicaid. Providers must report any outstanding credits owed to Medicaid that have not been reported previously on a Medicaid Credit Balance Report. However, hospital and nursing facility providers are required to submit a report every calendar quarter even if there are no credit balances. The report must be submitted no later than 30 days following the end of the calendar quarter (March 31, June 30, September 30, and December 31).
The Medicaid Credit Balance Report is used to monitor “credit balances” owed to the Medicaid program. A credit balance results from an improper or excess payment made to a provider. For example, refunds must be made to Medicaid if a provider is paid twice for the same service (e.g., by Medicaid and a medical insurance policy, by Medicare and Medicaid, by Medicaid and a liability insurance policy), if the patient liability was not reported in the billing process or if computer or billing errors occur.
For the purpose of completing the report, a Medicaid Credit Balance is the amount determined to be refundable to the Medicaid program. When a provider receives an improper or excess payment for a claim, it is reflected in the provider’s accounting records (patient accounts receivable) as a “credit.” However, credit balances include money due to Medicaid regardless of its classification in a provider’s accounting records. If a provider maintains a credit balance account for a stipulated period (e.g., 90 days) and then transfers the account or writes it off to a holding account, this does not relieve the provider of liability to the Medicaid program. The provider is responsible for identifying and repaying all monies owed the Medicaid program.
The Medicaid Credit Balance Report requires specific information on each credit balance on a claim-by-claim basis. The reporting form provides space for 15 claims but may be reproduced as many times as necessary to accommodate all the credit balances being reported. Specific instructions for completing the report are on the reverse side of the reporting form.
Submitting the Medicaid Credit Balance Report does not result in the credit balances automatically being reimbursed to the Medicaid program. A check is the preferred form of satisfying the credit balances; the check must be made payable to EDS and sent to EDS with the Medicaid Provider Refund Request Form attached for a refund. If an adjustment is to be made to satisfy the credit balance, the Medicaid Claim Adjustment Request Form must be completed and submitted to EDS with all the supporting documentation for processing.
|
Submit |
Submit |
Submit |
|
Third Party Recovery Section |
EDS |
EDS |
Submit only the completed Medicaid Credit Balance Report to DMA. Do not send refund checks or adjustment forms to DMA. Do not send the Credit Balance Report to EDS. Failure to submit a Medicaid Credit Balance Report will result in the withholding of Medicaid payment until the report is received.
The N.C. Medicaid Program’s provider enrollment
packets have been updated to include a Letter of Attestation as required
by Section 6023 of the Deficit Reduction Act (DRA) of 2005. Effective
To ensure that there is no delay in processing an enrollment application, providers should obtain the current version of the Provider Enrollment Packets from DMA’s website.
The process for submitting refunds to the N.C. Medicaid program has changed. Previously, the process stated that the provider should highlight the appropriate recipient information, claim information, and dollar amount of the refund on a copy of the Remittance Advice and Status Advice (RA) submitted with the refund check.
EDS recognizes that due to increasing number of providers receiving an electronic RA (835) or the potential for an RA to be used by more than one provider, the provider requesting a refund may not have an RA available to submit with a refund request. EDS has therefore developed the Medicaid Provider Refund Request form to replace the previous process for submitting refunds to Medicaid. The form, which can be completed and printed in Microsoft Excel, does not require a copy of the RA, claim forms, or other documentation to be submitted in order for EDS to process the refund.
In compliance with the Improper Payments Information Act of 2002, CMS implemented a Payment Error Rate Measurement (PERM) program to measure improper payments in the Medicaid program and the State Children’s Health Insurance Program (SCHIP). North Carolina has been selected as one of 17 states required to participate in PERM reviews of claims paid in federal fiscal year 2007 (October 1, 2006 through September 30, 2007).
CMS is using three national contractors to
measure improper payments. One of the contractors, Livanta
LLC (Livanta), will be communicating directly with providers and requesting
medical record documentation associated with the sampled claims (approximately
800 to 1200 claims for
Livanta began requesting medical records for the sampled
claims in
Providers are reminded of the requirement in Section 1902(a)(27) of the Social Security Act and 42 CFR Part 431.107 to retain any records necessary to disclose the extent of services provided to individuals and, upon request, furnish information regarding any payments claimed by the provider for rendering services.
Provider cooperation to furnish requested records is critical in this CMS project. No response to requests and/or insufficient documentation will be considered a payment error. This can result in a payback by the provider and a monetary penalty for the N.C. Medicaid program.
When first published, the October 2007 general Medicaid Bulletin included an article stating that recipients are allowed 30 visits per year, instead of the existing 24 visits. This article has since been revised. Session Law 2007-323 modified the law concerning Medicaid visit limitations. DMA is in the process of implementing these changes and a detailed bulletin article will be published as we get closer to completion of the project.
The Program of All-inclusive Care for the Elderly (PACE) is a managed care program that enables elderly individuals who are certified to need nursing facility care to live as independently as possible. The PACE provider receives monthly Medicare and/or Medicaid capitation payments for each eligible enrollee. The PACE provider assumes full financial risk for participants’ care without limits on amount, duration or scope of services. Medicaid will not reimburse non-PACE providers for services provided to PACE participants.
Effective
Note: Currently, PACE is available only in New Hanover and
Services provided directly by the PACE provider include, but are not limited to
Basic Medicaid seminars will be held in April 2008. Registration information, a list of dates, and site locations for the seminars are listed below.
Seminars will begin at
Due to limited seating, registration is limited to two staff members per office. Preregistration is required. Unregistered providers are welcome to attend if space is available. Providers may register for the seminars by completing and submitting the Online Registration Form. Providers may also complete the paper version of the Seminar Registration Form and fax it to the number listed on the form. Please indicate on the registration form the session you plan to attend.
The Basic Medicaid Billing Guide will be used as the primary training document for the seminar. Please review and print the April 2008 version and bring it to the seminar. The April 2008 Basic Medicaid Billing Guide will be available the first week of March 2008.
|
Morganton 828-438-6000 |
336-767-9595 |
|
910-763-2800 |
919-621-0540 |
Directions to the Basic Medicaid Seminars:
Western Piedmont Community College –
From
Traveling East on I-40
From
Traveling on NC 18 from Lenoir
Turn left onto South Sterling Street. Turn right
at Burger King onto W. Fleming Drive. At the
Traveling on NC 64 from Rutherfordton
Driving into Morganton, cross over
I-40.
Holiday Inn Select –
Take I-40 to the NC 52 North exit. Travel
eight miles to exit 115B (University Pkwy South). The Holiday
Inn Select is located on the right.
Traveling North on NC 52
Take NC 52 South to University Parkway, exit 115. Keep right at the fork
to go on University Parkway.
Traveling South on NC 52
Take NC 52 North to University Parkway South, exit 115B. The Holiday Inn
Select is located on the right.
Coastline Convention Center –
Take I-40 East towards
Traveling South on US 17
As you approach
Traveling North on US 17 or NC 74/76
After crossing the Cape Fear Memorial Bridge
into
The Royal Banquet Center – Raleigh, NC
Traveling West on I-40
Take I-40 West towards Raleigh. Take the Wade Avenue exit. Merge onto I-440 S/US 1 South toward
I-40 East/Hillsborough Street/Sanford. Take Exit 3 for NC
54/Hillsborough Street. Turn left onto Hillsborough Street/NC
54. Turn right at the 3rd traffic light at Meredith College
and Playmakers (the turn is located in front of Quizno's and Ben & Jerry's). Go
to the end of the parking lot and turn left to park BEHIND the building
or in the covered parking area.
Traveling East on I-40
Take I-40 East into
The N.C. Medicaid program must have the correct tax information on file for all providers. This ensures that 1099 MISC forms are issued correctly each year and that correct tax information is provided to the IRS. Incorrect information on file with Medicaid can result in the IRS’s withholding 28% of a provider’s Medicaid payments. The individual responsible for maintenance of tax information must receive the information contained in this article.
How to Verify Tax Information
The last page of the Medicaid Remittance
and Status Report (RA) indicates the tax name and number on file with Medicaid
for the provider number listed. Review the Medicaid RA throughout
the year to ensure that the correct tax information is on file for each
provider number. If you do not have access to a Medicaid
RA, call EDS Provider Services at 919-851-8888 or 1-800-688-6696 to verify
the tax information on file for each provider.
How to Correct Tax Information
All providers are required to complete
a W-9 form for each provider for whom incorrect information is on file. Please
go to the following website to obtain a copy of a W-9
form. Correct
information must be received by
All providers who identify incorrect tax information must submit a completed and signed W-9 form along with a completed and signed Medicaid Provider Change form to the address listed below:
Division of Medical Assistance - Provider
Services
2501 Mail Service Center
Effective with date of service December 13, 2007, and until further notice, N.C. Medicaid will reimburse for purchased PedvaxHIB (CPT procedure code 90467) or ActHIB (CPT procedure code 90468), when administered to recipients through 18 years of age because of a recent vaccine recall and a resulting shortage.
On
The decision about whether the child should receive a two- or three-dose series depends on the vaccine product used. Please refer to the following table for guidelines.
|
Population |
Administration Guidelines |
|---|---|
|
Children receiving PedvaxHIB at 2 months and 4 months of age |
Primary series complete; no booster during the suspension unless high-risk |
|
Children receiving PedvaxHIB at 2 months of age and ActHIB at 4 months of age |
One more dose of ActHIB at 6 months to complete primary series; no booster during the suspension unless high risk |
|
Children receiving all doses ActHIB |
2, 4, and 6 months to complete the primary series; no booster during the suspension unless high risk |
The SC modifier must be appended to the procedure code to indicate that purchased vaccine was administered.
Medicaid continues to reimburse for the Hib vaccine for high-risk recipients according to the existing recommendations of the Advisory Committee on Immunization Practices. Other billing requirements regarding vaccines also remain in effect.
EPSDT allows a recipient less than 21 years of age to receive services in excess of the limitations or restrictions indicated above and without meeting the specific criteria in this section when such services are medically necessary health care services to correct or ameliorate a defect, physical or mental illness, or a condition (health problem); that is, documentation shows how the service, product, or procedure will correct or improve or maintain the recipient’s health in the best condition possible, compensate for a health problem, prevent it from worsening, or prevent the development of additional health problems.
EPSDT DOES NOT ELIMINATE THE REQUIREMENT FOR PRIOR APPROVAL IF PRIOR APPROVAL IS REQUIRED. Additional information on EPSDT guidelines may be accessed on the EPSDT webpage for providers.
The web-based Medicaid Uniform Screening Tool (MUST) will soon replace the FL2, the FL2e, the Pre-Admission Screening and Annual Resident Review Level I screen, telephone prior approvals for nursing facility level of care, the Community Alternatives Program for Children (CAP/C) Referral form, the Nursing Facility Tracking form, and the Ventilator Addendum form used to screen applicants and to document their medical, functional, and behavioral health status. Initially, the MUST will be used prior to entry into the following Medicaid covered services/facilities:
Authorized and trained screeners (local professionals) will enter the medical, functional and behavioral health information into the automated web-based tool. The data will be processed through a rules engine that contains the clinical coverage criteria as documented in the Medicaid program’s clinical coverage policies.
A “best fit” service will be presented to the screener, along with other service options for which the recipient may apply. The screener and the applicant will jointly determine which service option to select and the screener can then make a referral to the service provider.
Eligible screeners include
1. Clinical professionals utilizing MUST to make a referral to Medicaid for long-term-care services and supports (covered under the Uniform Screening Program and expanding over time), including
a. physicians
b. physician assistants, family nurse practitioners, and other mid-level practitioners
c. registered nurses and licensed practical nurses
d. medical/clinical social workers, qualified professionals, and psychologists
2. Hospital discharge planners and case managers who make referrals to long-term-care services and supports
3. Case managers from regional, local, and community organizations who make referrals to long-term-care services and supports.
4. Staff of Aging Disability Resource Centers; local departments of social services; and other providers, agencies, and networks whose entity administrator determines the potential screener has the experience and informal training with which to complete the screenings.
All MUST screeners will be qualified to be screeners by participating in MUST training and by demonstrating competency in the use of the tool as evidenced by passing the MUST test. Ongoing authorization will be monitored through several DMA quality assurance initiatives. DMA reserves the right to revoke the screener’s access to the web-based MUST.
MUST is currently being field tested by a cross section of all provider groups mentioned above. This process consists of two testing periods: February 11 through March 14 for round No. 1 and March 31 through April 25 for round No. 2. Following each testing period, the current Uniform Screening Program contractor, EDS, will refine the tool. Regional training classes will be held across the state once field testing is completed.
MUST regional training is scheduled
to begin
Once a screener attends the training and
passes the test, he/she may begin using the MUST to replace the FL2 in
the work flow. No FL2 or FL2e will be accepted after
The
The survey will be available March 1 through 16, 2008, via a link on the CCME website for Prior Authorization. Please share your opinions with CCME by completing this brief survey. Your feedback and comments are greatly appreciated.
The
The first quarterly training session this year will
be held on
The seminar is scheduled to begin at 9:00 a.m. and end at 3:00 p.m. The session will focus on Resource Utilization Group (RUG) scores, accurately completing the three parts of the AQUIP tool (client information sheet, data set assessment, and plan of care), and resolving common data entry errors. The session will end with an overview of Health Check/Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) for Medicaid-eligible recipients under the age of 21.
Preregistration is required. Contact your
CAP/DA lead agency to verify if your name is on the required attendance
list. You may register for the seminar
online, beginning
The use of miscellaneous code T1999 is permitted only in instances where a medical supply item is needed and is medically necessary for the recipient’s treatment or illness, but no code describing the item is listed on the Home Health Fee schedule. The need for this code will continue with the ongoing updates and advances in medical treatment and the continual development of new and more effectual products. The use of this code is a provision made to allow billing and reimbursement for these supplies on a temporary basis.
A recent review of home health supply billing revealed that some providers are not adhering to coding guidelines regarding the use of the miscellaneous medical supply code T1999. Providers should refer to Section 3.6 of Clinical Coverage Policy #3A, Home Health Services, for complete instructions on billing supplies and the use of the miscellaneous medical supply code.
The Home Health Fee Schedule lists the Medicaid-covered home health medical supplies that can be reimbursed when billed by home health agencies, Community Alternatives Program (CAP) case managers, and private duty nursing providers. The Home Health Fee Schedule includes the applicable national HCPCS code for each covered supply code as mandated under HIPAA.
Periodic updates are made to the fee schedule to accommodate coding changes made by CMS and as needed to include the items that are medically necessary and reasonable to treat the illnesses, diseases, or injuries common to the Medicaid home care population. The codes generically describe the supply item and list the unit quantity measurement. Providers must use the national HCPCS code that fits the item description and bill the units accordingly. Misuse of code T1999 may result in the recoupment of any payment made for the medical supply item billed.
Clinical Policy and Programs
DMA, 919-855-4380
It has come to DMA’s attention that some providers continue to receive claim denials when billing certain laboratory procedure codes with modifier QW. In order to ensure that claims are coded appropriately when submitted, providers should refer to the CMS website at http://www.cms.hhs.gov/CLIA/10_Categorization_of_Tests.asp for the current lists as follows:
The lists may be printed and retained for future reference; however, this information is periodically updated and new tests are added as they are approved.
Billing Reminders
If a CPT code is listed with the QW modifier on the list of waived tests, the modifier must be appended to the CPT code for reimbursement. Failure to append the QW modifier will result in claims being denied for EOB 0936, “Certification not valid for DOS/Level.” Claims submitted with the QW modifier appended to a CPT code that is not indicated on the list of waived tests will also deny for EOB 0936.
If a test is not included on the QW list, providers should contact CLIA at the Licensure and Certification Section of the N.C. Division of Health Service Regulation at 919-855-4620 to discuss their certificate type and the tests that can be performed based on the certificate type.
This article, originally published in the February 2008 general Medicaid Bulletin, includes information on additional bill type changes.
The National Uniform Billing Committee (NUBC)
previously released the UB-04 paper claim and manual for billing. DMA
will implement claim processing modifications on
|
Form Locator |
Description |
|---|---|
|
FL 4 |
Type of Bill (including the Type of Bill Frequency codes) |
|
FL 14 |
Priority (Type) of Visit |
|
FL 15 |
Source of Referral for Admission or Visit |
|
FL 17 |
Patient Discharge Status |
|
FL 18 through 28 |
Condition Codes |
|
FL 31 through 34 |
Occurrence Codes and Dates |
|
FL 35 through 36 |
Occurrence Span Codes and Dates |
|
FL 39 through 41 |
Value Codes and Amounts |
|
FL 42 |
Revenue Code |
Bill Type Changes
Due to a definition change in the UB-04 Manual,
the following Bill Types are required for claims received on or after
Revenue Code Changes
Due to a definition change in the UB-04 Manual
claims received on or after
Priority (Type) of Visit Changes
DMA will allow code 5 defined as Trauma in
FL 14 for claims received on or after
Patient Discharge Status Changes
DMA will allow code 70 defined as Discharged/Transferred
to another Type of Health Care Institution not Defined Elsewhere in this
code list in FL 17 for claims received on or after April 25, 2008.
The National Uniform Billing Committee (NUBC) has issued the revised institutional paper claim format.
All institutional paper claims received on
or after
Providers who submit the UB-92 claim form
for processing on or after
Refer to the June 2007 Special Bulletin, New Claim Form Instructions, and the NUBC website for specific billing guidelines.
Submitting an accurate days supply is important. Daily supply should be determined from the directions for use and the quantity written on a prescription. For a prescription with instructions “use as directed,” the pharmacist should estimate the days supply based on professional judgment and/or contact with the prescriber. The maximum days supply for drugs is 34 days unless the drug meets the criteria to obtain a 90 days supply.
Please refer to the Clinical Coverage Policy #9, Outpatient Pharmacy Program, for additional information on days supply.
The following changes are being made for manufacturers with drug rebate agreements. The changes are listed by manufacturer code, which are the first five digits of the National Drug Code.
Additions
The following labelers have entered into
drug rebate agreements and have joined the rebate program effective on
the dates indicated below:
|
Code |
Manufacturer |
Date |
|---|---|---|
|
67877 |
Ascend Laboratories LLC |
|
|
00086 |
Elan Pharmaceuticals, Inc. |
|
Voluntarily Terminated Labeler
The following labeler has requested
voluntary termination effective on the date below:
|
Code |
Manufacturer |
Date |
|---|---|---|
|
51284 |
Zila Pharmaceuticals, Inc. |
|
In accordance with NCGS §108A-54.2, proposed new or amended Medicaid clinical coverage policies are available for review and comment on DMA’s website. To submit a comment related to a policy, refer to the instructions on the Proposed Clinical Coverage Policies web page. Providers without Internet access can submit written comments to the address listed below.
Loretta Bohn
Division of Medical Assistance
Clinical Policy Section
2501 Mail Service Center
The initial comment period for each proposed policy is 45 days. An additional 15-day comment period will follow if a proposed policy is revised as a result of the initial comment period.
|
Month |
Electronic Cut-Off Date |
Checkwrite Date |
|
March 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April |
|
|
|
|
|
|
|
|
|
Electronic claims must be
transmitted and completed by
| William W. Lawrence, Jr. M.D. Acting Director Division of Medical Assistance Department of Health and Human Services |
Cheryll Collier Executive Director EDS |